中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
长春应用化学研究所 [3]
上海药物研究所 [1]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2014 [1]
2012 [1]
2011 [1]
2006 [1]
学科主题
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
作者升序
作者降序
NIR-Responsive Upconversion Nanoparticles Stimulate Neurite Outgrowth in PC12 Cells
期刊论文
OAI收割
small, 2014, 卷号: 10, 期号: 18, 页码: 3655-3661
Guan, Yijia
;
Li, Meng
;
Dong, Kai
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2015/03/26
GOLD NANOPARTICLES
ALZHEIMERS-DISEASE
SMALL ANIMALS
DIFFERENTIATION
CULTURE
CARBON
FABRICATION
SUBSTRATE
THERAPY
RELEASE
Inhibition of metal-induced amyloid aggregation using light-responsive magnetic nanoparticle prochelator conjugates
期刊论文
OAI收割
chemical science, 2012, 卷号: 3, 期号: 3, 页码: 868-873
Li M
;
Liu Z
;
Ren JS
;
Qu XG
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2013/08/29
ALZHEIMERS-DISEASE
BETA-PEPTIDE
CONTROLLED-RELEASE
A-BETA
TRANSGENIC MICE
DRUG-DELIVERY
ZINC-BINDING
COPPER
THERAPY
ACETYLCHOLINESTERASE
Resonance light scattering as a powerful tool for sensitive detection of beta-amyloid peptide by gold nanoparticle probes
期刊论文
OAI收割
chemical communications, 2011, 卷号: 47, 期号: 33, 页码: 9339-9341
Wang CK
;
Liu DJ
;
Wang ZX
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2012/06/12
ALZHEIMERS-DISEASE
DNA HYBRIDIZATION
HYPOTHESIS
ASSAY
AGGREGATION
PROTEINS
THERAPY
FLUID
progressinstudiesofhuperzineaanaturalcholinesteraseinhibitorfromchineseherbalmedicine
期刊论文
OAI收割
actapharmacologicasinica, 2006, 卷号: 27, 期号: 1, 页码: 1
作者:
Rui Wang
;
Han Yan
;
Xican Tang
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/07/01
RAT PHEOCHROMOCYTOMA CELLS
NERVE GROWTH-FACTOR
AMYLOID PRECURSOR PROTEIN
SPATIAL WORKING-MEMORY
LONG-TERM POTENTIATION
EXPERIMENTAL COGNITIVE IMPAIRMENT
DISSOCIATED HIPPOCAMPAL-NEURONS
ALZHEIMERS-DISEASE THERAPY
OXYGEN-GLUCOSE DEPRIVATION
CENTRAL CHOLINERGIC SYSTEM
huperzine A
Alzheimer disease
acetylcholinesterase
cholinesterase inhibitors
cognitive enhancer
neuroprotect agents
oxidative stress
apoptosis